The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial.
- Published In:
- Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 37(12), 2435-2442 (2022)
- Authors:
- Czerwinski, Edward, Cardona, Jose, Plebanski, Rafal, Recknor, Chris, Vokes, Tamara, Saag, Kenneth G, Binkley, Neil, Lewiecki, E Michael, Adachi, Jonathan, Knychas, Dorota, Kendler, David, Orwoll, Eric, Chen, Yinzhong, Pearman, Leny, Li, Y Heather, Mitlak, Bruce
- Database ID:
- RPEP-06070
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06070APA
Czerwinski, Edward; Cardona, Jose; Plebanski, Rafal; Recknor, Chris; Vokes, Tamara; Saag, Kenneth G; Binkley, Neil; Lewiecki, E Michael; Adachi, Jonathan; Knychas, Dorota; Kendler, David; Orwoll, Eric; Chen, Yinzhong; Pearman, Leny; Li, Y Heather; Mitlak, Bruce. (2022). The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 37(12), 2435-2442. https://doi.org/10.1002/jbmr.4719
MLA
Czerwinski, Edward, et al. "The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial.." Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2022. https://doi.org/10.1002/jbmr.4719
RethinkPeptides
RethinkPeptides Research Database. "The Efficacy and Safety of Abaloparatide-SC in Men With Oste..." RPEP-06070. Retrieved from https://rethinkpeptides.com/research/czerwinski-2022-the-efficacy-and-safety
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.